BioNeutra Global Corp Total Liabilities

Latest as of September 2024: CA$21.81 Million CAD ≈ $15.77 Million USD

BioNeutra Global Corp total liabilities. Based on the latest financial reports, BioNeutra Global Corp (BGA) has total liabilities worth CA$21.81 Million CAD (≈ $15.77 Million USD) as of September 2024. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check BioNeutra Global Corp liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of BioNeutra Global Corp (2013–2023)

Total liabilities of BioNeutra Global Corp from 2013 to 2023. This chart illustrates how BioNeutra Global Corp's total liabilities have evolved over time, based on quarterly financial data. Explore BGA long-term asset investment ratio to see how much of total assets are deployed in long-term investments.

BioNeutra Global Corp Competitors by Total Liabilities

The table below lists competitors of BioNeutra Global Corp ranked by their total liabilities.

Company Country Total Liabilities
Avation PLC
LSE:AVAP
UK GBX762.44 Million
Lucky Minerals Inc
V:LKY
Canada CA$8.24 Million
PHAXIAM Therapeutics S.A.
PA:PHXM
France €23.66 Million
Made Tech Group PLC
LSE:MTEC
UK GBX7.58 Million
Venture Life Group PLC
LSE:VLG
UK GBX17.76 Million
Antarctica Limited
NSE:ANTGRAPHIC
India Rs374.55 Million
Eurasia Mining
LSE:EUA
UK GBX1.88 Million
Team Internet Group PLC
LSE:TIG
UK GBX363.80 Million

Liability Composition Analysis (2013–2023)

This chart breaks down BioNeutra Global Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see BGA asset base.

Liquidity & Leverage Metrics

BioNeutra Global Corp Total Liabilities Ratios Explained

BioNeutra Global Corp total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 0.35 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity -2.65 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 1.61 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how BioNeutra Global Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for BioNeutra Global Corp (2013–2023)

The table below shows the annual total liabilities of BioNeutra Global Corp from 2013 to 2023.

Year Total Liabilities Change
2023-12-31 CA$21.96 Million
≈ $15.89 Million
-6.70%
2022-12-31 CA$23.54 Million
≈ $17.03 Million
+6.42%
2021-12-31 CA$22.12 Million
≈ $16.00 Million
-3.74%
2020-12-31 CA$22.98 Million
≈ $16.62 Million
-21.51%
2019-12-31 CA$29.27 Million
≈ $21.18 Million
+33.49%
2018-12-31 CA$21.93 Million
≈ $15.86 Million
+28.88%
2017-12-31 CA$17.01 Million
≈ $12.31 Million
-18.26%
2016-12-31 CA$20.81 Million
≈ $15.06 Million
+79.56%
2015-12-31 CA$11.59 Million
≈ $8.39 Million
+263.80%
2014-12-31 CA$3.19 Million
≈ $2.30 Million
-25.00%
2013-12-31 CA$4.25 Million
≈ $3.07 Million
--

About BioNeutra Global Corp

V:BGA Canada Packaged Foods
Market Cap
$1.01 Million
CA$1.39 Million CAD
Market Cap Rank
#30669 Global
#1571 in Canada
Share Price
CA$0.03
Change (1 day)
+0.00%
52-Week Range
CA$0.03 - CA$0.03
All Time High
CA$0.90
About

BioNeutra Global Corporation engages in the research and development, production, and commercialization of food for nutraceutical, functional, and mainstream food and beverage products with a focus on oligosaccharides. The company offers isomalt oligosaccharide ingredients under the VitaFiber brand for human digestive health. It operates in Canada, the United States, Australia, New Zealand, Europ… Read more